Allarity Therapeutics (ALLR) Shares Issued (2020 - 2026)

Allarity Therapeutics' (ALLR) quarterly Shares Issued came in at $98444.0 in Q1 2026, up 96.89% on a QoQ basis from $50000.0 in Q4 2025.

Allarity Therapeutics (ALLR) Shares Issued (2020 - 2026) Analysis & Trends

Allarity Therapeutics (ALLR) has 7 years of Shares Issued data on file, last reported at $98444.0 in Q1 2026.

Quarterly Shares Issued changed N/A year-over-year to $98444.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98444.0 (changed N/A YoY) and the FY2025 annual result came in at $50000.0, changed N/A from the prior year.
Shares Issued grew to $98444.0 in Q1 2026, from $50000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $1.2 million in Q1 2022 to a low of $6.0 in Q3 2024.
A 5-year average of $171959.4 and a median of $6108.0 in 2023 frame the typical range for Shares Issued.
Annual changes were most pronounced in 2022 — Shares Issued plunged 100.0% — and 2025, when it jumped 833233.33%.
Tracing ALLR's Shares Issued over 5 years: stood at $10.0 in 2022, then declined by 10.0% to $9.0 in 2023, then plunged by 33.33% to $6.0 in 2024, then jumped by 833233.33% to $50000.0 in 2025, then jumped by 96.89% to $98444.0 in 2026.
The last three Shares Issued figures came in at $98444.0 (Q1 2026), $50000.0 (Q4 2025), and $50000.0 (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Allarity Therapeutics	22.75 Mn	22.75 Mn	-	717,941.00

Download Data